Clinical impact of c-KIT and CEBPA mutations in 33 patients with corebinding factor (Non-M3) acute myeloid leukemia
Background: Corebinding factor acute myeloid leukemia (CBF-AML) is the most common cytogenetic subtype of pediatric AML. CBF-AML is associated with a relatively favorable outcome, although the relapse rate of approximately 40% indicates a high degree of clinical heterogeneity. The clinical impact of...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2023-07-01
|
| Col·lecció: | Pediatrics and Neonatology |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S1875957223000190 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|